Researchers investigated the influence of metformin on patient survival and its potential correlation with distinct immune profiles in PDAC tumors.
[JNCI-Journal Of The National Cancer Institute]
Home Newsletters Metformin Boosts Anti-tumor Immunity and Improves Prognosis in Upfront Resected Pancreatic Cancer:...
